Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mitsuji, Katori"'
Autor:
Kazuhito Suzuki, Kaichi Nishiwaki, Tadahiro Gunji, Mitsuji Katori, Hidekazu Masuoka, Shingo Yano
Publikováno v:
Cancer Medicine, Vol 9, Iss 5, Pp 1694-1702 (2020)
Abstract Lenalidomide is an immunomodulatory drug that is administered commonly in patients with relapsed or refractory multiple myeloma (RRMM). Eosinophils have immunological functions, for instance, in allergic diseases and asthma. The purpose of t
Externí odkaz:
https://doaj.org/article/49ae5377ef4c466aa404f2a9596791a0
Autor:
Kazuhito Suzuki, Shingo Yano, Kaichi Nishiwaki, Koji Sano, Takaki Shimada, Yuichi Yahagi, Yoji Ogasawara, Katsuki Sugiyama, Shinobu Takahara, Takeshi Saito, Kinuyo Kasama, Jiro Minami, Hiroki Yokoyama, Yutaro Kamiyama, Atsushi Katsube, Hidekazu Masuoka, Mitsuji Katori, Tomohito Machishima, Aya Ouchi, Nobuaki Dobashi, Ken Kaito, Noriko Usui, Keisuke Aiba
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3051-3058 (2016)
Abstract The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to investigate the clinical significance of granule‐containing myeloma cells in patients wit
Externí odkaz:
https://doaj.org/article/2620492b797f4764b73082a649898233
Autor:
Kaichi Nishiwaki, H Masuoka, Kazuhito Suzuki, Mitsuji Katori, Shingo Yano, Daiki Hattori, Ryoko Fukushima, Riku Nagao
Publikováno v:
International Journal of Hematology. 114:599-607
Minimal residual disease (MRD) is a surrogate marker for survival in multiple myeloma (MM), while the lymphocyte-to-monocyte ratio (LMR) is a prognostic factor associated with the patients' immunological status. We retrospectively evaluated the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366e925f107aa7d04ae033beb3be91ef
https://doi.org/10.1007/s12185-021-03201-y
https://doi.org/10.1007/s12185-021-03201-y
Autor:
Kazuhito Suzuki, Kaichi Nishiwaki, Riku Nagao, Mitsuji Katori, Ryoko Fukushima, Yo Sakayori, Hidekazu Masuoka, Shingo Yano
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S85-S86
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d05af6246df27f05e50d051cf30f4f09
https://doi.org/10.1016/s2152-2650(22)00421-9
https://doi.org/10.1016/s2152-2650(22)00421-9
Autor:
Susumu Tanoue, Kazuhito Suzuki, Mitsuji Katori, Yuta Ito, Shingo Yano, H Masuoka, Daiki Hattori, Kaichi Nishiwaki, Shinichi Hirooka, Haruka Matsuzawa
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 61:224-226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8350d5e6867dd8c3a9909384a9570d9a
https://doi.org/10.3960/jslrt.21009
https://doi.org/10.3960/jslrt.21009
Autor:
Hiroya, Namiki, Yuta, Ito, Haruka, Matsuzawa, Keitaro, Enoki, Kenji, Motohashi, Daiki, Hattori, Susumu, Tanoue, Kazuhito, Suzuki, Mitsuji, Katori, Shinichi, Hirooka, Hidekazu, Masuoka, Shunichi, Sadaoka, Kaichi, Nishiwaki, Shingo, Yano
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(1)
A 68-year-old male presented with appetite loss and abdominal distention. The whole-body computed tomography scan revealed an ileocecal mass with a large amount of ascites, which was consistent with malignant lymphoma. Due to the worsening of his gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1991bb252df13b88d20cd7b21d858957
https://pubmed.ncbi.nlm.nih.gov/33551427
https://pubmed.ncbi.nlm.nih.gov/33551427
Autor:
Naoto Takahashi, Kaichi Nishiwaki, Shingo Yano, Kazuhito Suzuki, Mitsuji Katori, Jun Miki, Masamichi Takagi, Makoto Odaka
Publikováno v:
Annals of Oncology. 32:S350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b49fe9000651f05f356e681d79fa403
https://doi.org/10.1016/j.annonc.2021.05.749
https://doi.org/10.1016/j.annonc.2021.05.749
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 5, Pp 1694-1702 (2020)
Cancer Medicine, Vol 9, Iss 5, Pp 1694-1702 (2020)
Lenalidomide is an immunomodulatory drug that is administered commonly in patients with relapsed or refractory multiple myeloma (RRMM). Eosinophils have immunological functions, for instance, in allergic diseases and asthma. The purpose of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca35ab0e39f4acecce10230f1062dcc7
https://pubmed.ncbi.nlm.nih.gov/31950647
https://pubmed.ncbi.nlm.nih.gov/31950647
Autor:
Yutaro Kamiyama, Yuichi Yahagi, Hiroki Yokoyama, Katsuki Sugiyama, Shingo Yano, Takeshi Saito, Kazuhito Suzuki, Noriko Usui, H Masuoka, Mitsuji Katori, Koji Sano, Shinobu Takahara, Nobuaki Dobashi, Yoji Ogasawara, Kaichi Nishiwaki, Ken Kaito, Aya Ouchi, Tomohito Machishima, Kinuyo Kasama, Jiro Minami, Atsushi Katsube, Keisuke Aiba, Takaki Shimada
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3051-3058 (2016)
Cancer Medicine
Cancer Medicine
The clinical features and prognostic significance of myeloma cells containing granules remain unclear. The purpose of this retrospective study was to investigate the clinical significance of granule‐containing myeloma cells in patients with newly d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca10f70e79f85550e518bcd0677d2695
https://doaj.org/article/2620492b797f4764b73082a649898233
https://doaj.org/article/2620492b797f4764b73082a649898233
Autor:
Yuta Ito, Kaichi Nishiwaki, Haruka Matsuzawa, Daiki Hattori, Susumu Tanoue, Kazuhito Suzuki, Mitsuji Katori, Shinichi Hirooka, Hidekazu Masuoka, Shingo Yano
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2021, Vol. 61 Issue 4, p224-226, 3p